Increased osseointegration effect of bone morphogenetic protein 2 on dental implants

An in vivo study

Daniel Yoo, Nick Tovar, Ryo Jimbo, Charles Marin, Rodolfo B. Anchieta, Lucas S. Machado, Jin Montclare, Fernando P S Guastaldi, Malvin N. Janal, Paulo Coelho

Research output: Contribution to journalArticle

Abstract

Application of recombinant human bone morphogenetic protein 2 (rhBMP-2) to implant surfaces has been of great interest due to its osteoinductive potential. However, the optimal coating methodology has not been clarified. The objective of the study was to determine whether the application of rhBMP-2 onto plasma-sprayed hydroxyapatite implant surfaces by immersion in protein solution before implant installation would result in significantly improved bone apposition. Using a sheep iliac model, titanium (Ti) and plasma-sprayed calcium-phosphate (PSCaP)-coated implants uncoated and coated with rhBMP-2 were assessed for their osteogenic effects in the peri-implant area over time in terms of osseointegration and de novo bone formation. After 3 and 6 weeks postoperatively, the samples were retrieved and were subjected to bone-to-implant contact (BIC) and bone area fraction occupancy (BAFO) evaluation. When rhBMP-2 was applied to the PSCaP surface, significant increases in BIC and BAFO were observed at 3 weeks in vivo, whereas when adsorbed directly onto the titanium implant surface, rhBMP-2 did not as effectively improve the bone response (although significantly higher than control Ti). The outcomes of the present study suggested that the combination of plasma-sprayed calcium-phosphate surface and rhBMP-2 coating significantly enhanced osseointegration, which validated the postulated hypothesis.

Original languageEnglish (US)
Pages (from-to)1921-1927
Number of pages7
JournalJournal of Biomedical Materials Research - Part A
Volume102
Issue number6
DOIs
StatePublished - 2014

Fingerprint

Osseointegration
Bone Morphogenetic Protein 2
Dental prostheses
Dental Implants
Bone
Proteins
Bone and Bones
Titanium
Plasmas
Calcium phosphate
Coatings
Immersion
Durapatite
Osteogenesis
recombinant human bone morphogenetic protein-2
Sheep
Outcome Assessment (Health Care)
Hydroxyapatite
calcium phosphate

Keywords

  • bioactivity
  • bone morphogenic protein
  • calcium-phosphate
  • implant surface modification
  • release kinetics

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials
  • Ceramics and Composites
  • Metals and Alloys
  • Medicine(all)

Cite this

Increased osseointegration effect of bone morphogenetic protein 2 on dental implants : An in vivo study. / Yoo, Daniel; Tovar, Nick; Jimbo, Ryo; Marin, Charles; Anchieta, Rodolfo B.; Machado, Lucas S.; Montclare, Jin; Guastaldi, Fernando P S; Janal, Malvin N.; Coelho, Paulo.

In: Journal of Biomedical Materials Research - Part A, Vol. 102, No. 6, 2014, p. 1921-1927.

Research output: Contribution to journalArticle

Yoo, Daniel ; Tovar, Nick ; Jimbo, Ryo ; Marin, Charles ; Anchieta, Rodolfo B. ; Machado, Lucas S. ; Montclare, Jin ; Guastaldi, Fernando P S ; Janal, Malvin N. ; Coelho, Paulo. / Increased osseointegration effect of bone morphogenetic protein 2 on dental implants : An in vivo study. In: Journal of Biomedical Materials Research - Part A. 2014 ; Vol. 102, No. 6. pp. 1921-1927.
@article{b784362d55c94b7f940be722a6133858,
title = "Increased osseointegration effect of bone morphogenetic protein 2 on dental implants: An in vivo study",
abstract = "Application of recombinant human bone morphogenetic protein 2 (rhBMP-2) to implant surfaces has been of great interest due to its osteoinductive potential. However, the optimal coating methodology has not been clarified. The objective of the study was to determine whether the application of rhBMP-2 onto plasma-sprayed hydroxyapatite implant surfaces by immersion in protein solution before implant installation would result in significantly improved bone apposition. Using a sheep iliac model, titanium (Ti) and plasma-sprayed calcium-phosphate (PSCaP)-coated implants uncoated and coated with rhBMP-2 were assessed for their osteogenic effects in the peri-implant area over time in terms of osseointegration and de novo bone formation. After 3 and 6 weeks postoperatively, the samples were retrieved and were subjected to bone-to-implant contact (BIC) and bone area fraction occupancy (BAFO) evaluation. When rhBMP-2 was applied to the PSCaP surface, significant increases in BIC and BAFO were observed at 3 weeks in vivo, whereas when adsorbed directly onto the titanium implant surface, rhBMP-2 did not as effectively improve the bone response (although significantly higher than control Ti). The outcomes of the present study suggested that the combination of plasma-sprayed calcium-phosphate surface and rhBMP-2 coating significantly enhanced osseointegration, which validated the postulated hypothesis.",
keywords = "bioactivity, bone morphogenic protein, calcium-phosphate, implant surface modification, release kinetics",
author = "Daniel Yoo and Nick Tovar and Ryo Jimbo and Charles Marin and Anchieta, {Rodolfo B.} and Machado, {Lucas S.} and Jin Montclare and Guastaldi, {Fernando P S} and Janal, {Malvin N.} and Paulo Coelho",
year = "2014",
doi = "10.1002/jbm.a.34862",
language = "English (US)",
volume = "102",
pages = "1921--1927",
journal = "Journal of Biomedical Materials Research",
issn = "1549-3296",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Increased osseointegration effect of bone morphogenetic protein 2 on dental implants

T2 - An in vivo study

AU - Yoo, Daniel

AU - Tovar, Nick

AU - Jimbo, Ryo

AU - Marin, Charles

AU - Anchieta, Rodolfo B.

AU - Machado, Lucas S.

AU - Montclare, Jin

AU - Guastaldi, Fernando P S

AU - Janal, Malvin N.

AU - Coelho, Paulo

PY - 2014

Y1 - 2014

N2 - Application of recombinant human bone morphogenetic protein 2 (rhBMP-2) to implant surfaces has been of great interest due to its osteoinductive potential. However, the optimal coating methodology has not been clarified. The objective of the study was to determine whether the application of rhBMP-2 onto plasma-sprayed hydroxyapatite implant surfaces by immersion in protein solution before implant installation would result in significantly improved bone apposition. Using a sheep iliac model, titanium (Ti) and plasma-sprayed calcium-phosphate (PSCaP)-coated implants uncoated and coated with rhBMP-2 were assessed for their osteogenic effects in the peri-implant area over time in terms of osseointegration and de novo bone formation. After 3 and 6 weeks postoperatively, the samples were retrieved and were subjected to bone-to-implant contact (BIC) and bone area fraction occupancy (BAFO) evaluation. When rhBMP-2 was applied to the PSCaP surface, significant increases in BIC and BAFO were observed at 3 weeks in vivo, whereas when adsorbed directly onto the titanium implant surface, rhBMP-2 did not as effectively improve the bone response (although significantly higher than control Ti). The outcomes of the present study suggested that the combination of plasma-sprayed calcium-phosphate surface and rhBMP-2 coating significantly enhanced osseointegration, which validated the postulated hypothesis.

AB - Application of recombinant human bone morphogenetic protein 2 (rhBMP-2) to implant surfaces has been of great interest due to its osteoinductive potential. However, the optimal coating methodology has not been clarified. The objective of the study was to determine whether the application of rhBMP-2 onto plasma-sprayed hydroxyapatite implant surfaces by immersion in protein solution before implant installation would result in significantly improved bone apposition. Using a sheep iliac model, titanium (Ti) and plasma-sprayed calcium-phosphate (PSCaP)-coated implants uncoated and coated with rhBMP-2 were assessed for their osteogenic effects in the peri-implant area over time in terms of osseointegration and de novo bone formation. After 3 and 6 weeks postoperatively, the samples were retrieved and were subjected to bone-to-implant contact (BIC) and bone area fraction occupancy (BAFO) evaluation. When rhBMP-2 was applied to the PSCaP surface, significant increases in BIC and BAFO were observed at 3 weeks in vivo, whereas when adsorbed directly onto the titanium implant surface, rhBMP-2 did not as effectively improve the bone response (although significantly higher than control Ti). The outcomes of the present study suggested that the combination of plasma-sprayed calcium-phosphate surface and rhBMP-2 coating significantly enhanced osseointegration, which validated the postulated hypothesis.

KW - bioactivity

KW - bone morphogenic protein

KW - calcium-phosphate

KW - implant surface modification

KW - release kinetics

UR - http://www.scopus.com/inward/record.url?scp=84899438235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899438235&partnerID=8YFLogxK

U2 - 10.1002/jbm.a.34862

DO - 10.1002/jbm.a.34862

M3 - Article

VL - 102

SP - 1921

EP - 1927

JO - Journal of Biomedical Materials Research

JF - Journal of Biomedical Materials Research

SN - 1549-3296

IS - 6

ER -